The stock has been on a tear over the past month, but the next leg higher is far from assured. Munich Re closed at €515.60 on Friday, its highest level in four weeks, marking a 0.74% gain and a clear break above the 100-day moving average. The rally has lifted the shares 17.85% from the 52-week low of €437.50 hit on June 2, yet the path to reclaiming the August 2025 peak of €605.00 remains steep — a 15% climb. More immediately, the 200-day moving average at €522.90 sits just 1.4% above the current price, and the relative strength index at 69.2 is hovering near the overbought threshold of 70.
While the chart encourages short-term bulls, the company has been quietly deploying capital on the other side of the trade. Between late June and July 8, Munich Re bought back 56,650 of its own shares under a €2.25 billion programme authorised by the annual general meeting in May and running until the 2027 AGM. The buyback follows a record net profit of €6.1 billion for the 2025 financial year and a dividend hike from €20.00 to €24.00 per share, reinforcing management’s commitment to returning excess capital to shareholders.
That confidence comes against a backdrop of stiffening headwinds in the core reinsurance business. The July renewal season saw property-catastrophe premiums on loss-free contracts fall by 15% to 20%, according to industry reports, as a record global supply of $805 billion in capital intensified competition among carriers. Larger, diversified reinsurers like Munich Re are better positioned to weather the squeeze than smaller specialists, but the pricing downdraft is nonetheless a drag on growth prospects.
Should investors sell immediately? Or is it worth buying Münchener Rück?
Analysts remain split on how to weigh these conflicting forces. JPMorgan reaffirmed its “Overweight” rating and €590 price target on July 17, citing subdued catastrophe losses in the second quarter that prompted an upward revision to its 2026 net profit forecast. The bank is underweight the insurance sector overall in favour of banks, but sees selective opportunities in names with clear capital-return catalysts. Berenberg takes a more cautious stance with a “Hold” rating and €565 target, while Jefferies also rates the stock “Hold” but sets a higher price objective of €600.
The half-year financial report, due in early August, will provide the next major test. Investors will scrutinise how much of the July renewal price weakness has already filtered into the numbers and whether the buyback tempo can be sustained. For now, the 200-day moving average at €522.90 is the critical technical hurdle. A decisive breakout would lend support to the optimistic JPMorgan thesis, while a failure to clear it could vindicate the more cautious assessments from Berenberg and Jefferies — especially as the broader reinsurance earnings season gets underway.
Ad
Münchener Rück Stock: Buy or Sell?! New Münchener Rück Analysis from July 19 delivers the answer:
The latest Münchener Rück figures speak for themselves: Urgent action needed for Münchener Rück investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 19.
Münchener Rück: Buy or sell? Read more here...
